查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596492

智慧药物和药丸市场：按目标领域、类型、最终用户、应用 - 2025-2030 年全球预测

Smart Drugs & Pills Market by Target Area (Esophagus, Large Intestine, Small Intestine), Type (Over-the-Counter Nootropics, Prescription Nootropics), End User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年智慧药品市场价值为82.8亿美元，预计到2024年将达到101.8亿美元，复合年增长率为24.18%，预计到2030年将达到377.1亿美元。

智慧药物或锭剂，通常称为精神药物或认知增强剂，是旨在改善健康人的认知功能、记忆力、创造力和动机的物质。随着人们对增强智力和延长寿命的兴趣日益浓厚，市场范围扩大到包括药品、营养食品和机能性食品。这项需求源自于职业环境中认知需求的增加以及阿兹海默症和过动症等认知障碍盛行率的上升。应用范围广泛，涵盖医疗保健、学术、军事和企业部门，这些领域的认知增强受到高度重视。最终用途的范围在寻求头脑清晰和提高生活品质的学生、专业人士和老年人中尤其广泛。

主要市场统计
基准年[2023] 82.8亿美元
预测年份 [2024] 101.8亿美元
预测年份 [2030] 377.1亿美元
复合年增长率（%） 24.18%

市场成长受到生物技术进步、寻求认知支持的老龄化人口增加以及心理健康意识增强等因素的影响。提供轻鬆取得智慧型药物的数位平台的兴起也推动了市场扩张。个人化医疗的发展存在重大机会，它将人工智慧和机器学习相结合，根据个人需求量身定制认知增强解决方案。然而，市场成长受到监管监督、有关这些药物的滥用和长期安全性的道德争论以及消费者对功效和天然替代品不同看法的挑战。

创新机会在于增强药物输送系统，例如智慧药丸，透过感测器和无线连接来监测药物疗效和患者健康。科技和製药公司之间的合作可以推动精准医疗和资料分析的突破，从而改善使用者的治疗结果。儘管存在固有的挑战，但消费者对改善认知功能的需求持续成长，智慧药物市场也有望显着成长。鼓励公司投资于透明和道德的营销和研究，以增加消费者的信任并与监管环境保持一致，并且正在实施智能药物以在多方面的市场环境中增强认知能力，这是一种可能的选择。

市场动态：揭示快速发展的智慧药品和药丸市场的关键市场洞察

供需的动态交互作用正在改变智慧药品和药丸市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 老年人口增加，慢性病盛行率上升
    • 增加患者对微创手术的偏好以实现更好的诊断
    • 增强认知功能的智慧药物和药丸越来越受欢迎
  • 市场限制因素
    • 与智慧药物相关的高成本
  • 市场机会
    • 智慧药品的持续技术进步与创新
    • 加大智慧药品研发投入
  • 市场挑战
    • 与智能药物和药丸相关的副作用

波特五力：驾驭智慧药品和药丸市场的策略工具

波特的五力架构是了解智慧药物和药丸市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解智慧药品和药丸市场的外部影响

外部宏观环境因素在塑造智慧药物和药丸市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解智慧药品和药丸市场的竞争格局

智慧药物和药丸市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 智慧药品和药丸市场定位矩阵供应商绩效评估

FPNV 定位矩阵是评估智慧药品和药丸市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了智慧药品和药丸市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对智慧药物和药丸市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化加剧和慢性病盛行率上升
      • 越来越多的患者选择微创手术以获得更好的诊断
      • 改善认知功能的智慧药物和药丸越来越受欢迎
    • 抑制因素
      • 与智慧药物相关的高成本
    • 机会
      • 智慧药品的持续技术进步与创新
      • 加大研发投入 开发智慧药品和药丸
    • 任务
      • 与智能药物和药丸相关的副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章按目标区域分類的智慧药品和药丸市场

  • 食道
  • 冒号
  • 小肠
  • 胃

第七章智能药物和药丸市场：按类型

  • 非处方促智药
    • 咖啡因
    • 肌酸
    • L-茶氨酸
    • Omega-3脂肪酸
    • 消旋体
  • 无需处方笺的促智药

第八章智慧药品和药丸市场：依最终用户分类

  • 诊断中心
  • 医院
  • 调查机构

第九章智慧药品与药丸市场：依应用分类

  • 胶囊内视镜
  • 药物输送
  • 病患监测

第10章美洲的智慧药品和药丸市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太智慧药品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的智慧药品和药丸市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • BD 和 BIOCORP 签署协议，实现自我管理注射药物的连接和可追溯性
    • AARDEX 集团将 etectRx 添加到 MEMS 黏合硬体生态系统
    • Hamilton Beach Brands 和 Health Beacon 宣布在美国推出 Smart Sharp Corporation Bin(TM) 注射护理管理系统
    • AdhereTech 宣布与 AARDEX 集团合作，透过智慧药瓶、软体和资料分析提高用药依从性
    • Olympus迁至汉堡新总部 - 奥林巴斯欧洲、中东和非洲地区
    • 智慧药丸Start-UpsetectRx 与 Pear Therapeutics 合作
    • “CapsoVision Inc. 宣布 FDA 对 COVID-19 大流行期间在家进行胶囊内视镜检查 CapsoCam Plus 的执法自由裁量权”
  • 战略分析和建议

公司名单

  • Aardex Group
  • AnX Robotica Corp.
  • CapsoVision, Inc.
  • Check-Cap Ltd.
  • GE Healthcare
  • IntroMedic Co., Ltd.
  • Jinshan Science & Technology（Group）Co., Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Novartis AG
  • Olympus Corporation
  • RF Co., Ltd.
Product Code: MRR-43676CF42B9A

The Smart Drugs & Pills Market was valued at USD 8.28 billion in 2023, expected to reach USD 10.18 billion in 2024, and is projected to grow at a CAGR of 24.18%, to USD 37.71 billion by 2030.

Smart drugs and pills, often known as nootropics or cognitive enhancers, are substances designed to improve cognitive function, memory, creativity, or motivation in healthy individuals. With growing interest in enhancing mental performance and promoting longevity, the market scope has expanded to include pharmaceuticals, nutraceuticals, and functional foods. Their necessity stems from increasing cognitive demands in professional settings and the rising prevalence of cognitive impairments such as Alzheimer's and ADHD. Applications are widespread, spanning healthcare, academic, military, and corporate sectors where cognitive enhancement is highly valued. The end-use scope is particularly strong among students, professionals, and elderly populations seeking mental acuity and improved quality of life.

KEY MARKET STATISTICS
Base Year [2023] USD 8.28 billion
Estimated Year [2024] USD 10.18 billion
Forecast Year [2030] USD 37.71 billion
CAGR (%) 24.18%

Market growth is influenced by factors such as advancements in biotechnology, a growing aging population seeking cognitive support, and heightened awareness about mental health and wellness. The rise of digital platforms offering easy access to smart drugs also fuels market expansion. Notable opportunities exist in the development of personalized medicine, integrating AI and machine learning to tailor cognitive enhancement solutions to individual needs. However, market growth is challenged by regulatory scrutiny, ethical debates about the misuse and long-term safety of such drugs, and variable consumer perceptions regarding efficacy and natural alternatives.

Innovation opportunities lie in enhancing drug delivery systems like smart pills with sensors and wireless connectivity to monitor drug efficacy and patient health. Collaborations between technology companies and pharmaceutical firms can spur breakthroughs in precision medicine and data analytics to enhance user outcomes. Despite the inherent challenges, the smart drug market is poised for considerable growth as consumer demand for cognitive improvement continues to rise. Companies are recommended to invest in transparent, ethical marketing and research to align with regulatory standards while amplifying consumer trust, making smart drugs a viable option for cognitive enhancement in a multifaceted market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smart Drugs & Pills Market

The Smart Drugs & Pills Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing geriatric population coupled with rising prevalence of chronic disorders
    • Increased patient preference for minimally invasive surgeries for better diagnosis
    • Rising popularity of smart drugs & pills to enhance cognitive functions
  • Market Restraints
    • High cost associated with smart drugs & pills
  • Market Opportunities
    • Ongoing technological advancements and innovations in smart drugs & pills
    • Increasing research and development investment in developing smart drugs & pills
  • Market Challenges
    • Adverse reactions associated with smart drugs & pills

Porter's Five Forces: A Strategic Tool for Navigating the Smart Drugs & Pills Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smart Drugs & Pills Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smart Drugs & Pills Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smart Drugs & Pills Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smart Drugs & Pills Market

A detailed market share analysis in the Smart Drugs & Pills Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smart Drugs & Pills Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smart Drugs & Pills Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Smart Drugs & Pills Market

A strategic analysis of the Smart Drugs & Pills Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Smart Drugs & Pills Market, highlighting leading vendors and their innovative profiles. These include Aardex Group, AnX Robotica Corp., CapsoVision, Inc., Check-Cap Ltd., GE Healthcare, IntroMedic Co., Ltd., Jinshan Science & Technology (Group) Co., Ltd., Koninklijke Philips NV, Medtronic PLC, Novartis AG, Olympus Corporation, and RF Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Smart Drugs & Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Target Area, market is studied across Esophagus, Large Intestine, Small Intestine, and Stomach.
  • Based on Type, market is studied across Over-the-Counter Nootropics and Prescription Nootropics. The Over-the-Counter Nootropics is further studied across Caffeine, Creatine, L-theanine, Omega-3 fatty acids, and Racetams.
  • Based on End User, market is studied across Diagnostic Centers, Hospitals, and Research Institutes.
  • Based on Application, market is studied across Capsule Endoscopy, Drug Delivery, and Patient Monitoring.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing geriatric population coupled with rising prevalence of chronic disorders
      • 5.1.1.2. Increased patient preference for minimally invasive surgeries for better diagnosis
      • 5.1.1.3. Rising popularity of smart drugs & pills to enhance cognitive functions
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with smart drugs & pills
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements and innovations in smart drugs & pills
      • 5.1.3.2. Increasing research and development investment in developing smart drugs & pills
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse reactions associated with smart drugs & pills
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Smart Drugs & Pills Market, by Target Area

  • 6.1. Introduction
  • 6.2. Esophagus
  • 6.3. Large Intestine
  • 6.4. Small Intestine
  • 6.5. Stomach

7. Smart Drugs & Pills Market, by Type

  • 7.1. Introduction
  • 7.2. Over-the-Counter Nootropics
    • 7.2.1. Caffeine
    • 7.2.2. Creatine
    • 7.2.3. L-theanine
    • 7.2.4. Omega-3 fatty acids
    • 7.2.5. Racetams
  • 7.3. Prescription Nootropics

8. Smart Drugs & Pills Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Hospitals
  • 8.4. Research Institutes

9. Smart Drugs & Pills Market, by Application

  • 9.1. Introduction
  • 9.2. Capsule Endoscopy
  • 9.3. Drug Delivery
  • 9.4. Patient Monitoring

10. Americas Smart Drugs & Pills Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Smart Drugs & Pills Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Smart Drugs & Pills Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. BD, BIOCORP Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs
    • 13.3.2. AARDEX Group adds etectRx to their MEMS Adherence Hardware ecosystem
    • 13.3.3. Hamilton Beach Brands, Inc. and HealthBeacon plc Announce the US Launch of the Smart Sharps Bin(TM) Injection Care Management System
    • 13.3.4. AdhereTech Announces Partnership with AARDEX Group to Boost Medication Adherence with Smart Pill Bottle, Software and Data Analytics
    • 13.3.5. Olympus Moves into New Headquarters in Hamburg - Olympus EMEA
    • 13.3.6. Smart pill startup etectRx strikes partnership with Pear Therapeutics
    • 13.3.7. "CapsoVision Inc. Announces FDA Enforcement Discretion for At-Home Capsule Endoscopy Administration of CapsoCam Plus during COVID-19"
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aardex Group
  • 2. AnX Robotica Corp.
  • 3. CapsoVision, Inc.
  • 4. Check-Cap Ltd.
  • 5. GE Healthcare
  • 6. IntroMedic Co., Ltd.
  • 7. Jinshan Science & Technology (Group) Co., Ltd.
  • 8. Koninklijke Philips NV
  • 9. Medtronic PLC
  • 10. Novartis AG
  • 11. Olympus Corporation
  • 12. RF Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. SMART DRUGS & PILLS MARKET RESEARCH PROCESS
  • FIGURE 2. SMART DRUGS & PILLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SMART DRUGS & PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. SMART DRUGS & PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. SMART DRUGS & PILLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SMART DRUGS & PILLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SMART DRUGS & PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SMART DRUGS & PILLS MARKET DYNAMICS
  • TABLE 7. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY ESOPHAGUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY LARGE INTESTINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY SMALL INTESTINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY STOMACH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY CAFFEINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY CREATINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY L-THEANINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY OMEGA-3 FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY RACETAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY PRESCRIPTION NOOTROPICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SMART DRUGS & PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. SMART DRUGS & PILLS MARKET, FPNV POSITIONING MATRIX, 2023